| Stage | CMI | % of rev | CEPL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.4B | 100.00% | $25M | 100.00% | CMI ×378.69 |
| Gross profit | $2.6B | 27.71% | $9M | 35.15% | CEPL +7.4pp |
| Operating income | $1.3B | 13.95% | $967,000 | 3.88% | CMI +10.1pp |
| Pre-tax income | $1.4B | 15.05% | $42,000 | 0.17% | CMI +14.9pp |
| Net income | $1.2B | 12.39% | $37,000 | 0.15% | CMI +12.2pp |
| Stage | CMI | CEPL | Gap · A − B |
|---|---|---|---|
| Revenue | $9.4B100.00% | $25M100.00% | CMI ×378.69 |
| Gross profit | 27.71%$2.6B | 35.15%$9M | CEPL +7.4pp |
| Operating income | 13.95%$1.3B | 3.88%$967,000 | CMI +10.1pp |
| Pre-tax income | 15.05%$1.4B | 0.17%$42,000 | CMI +14.9pp |
| Net income |
| 12.39%$1.2B |
| 0.15%$37,000 |
| CMI +12.2pp |
No disclosed counterparties: CEPL.
None